Treatment-resistant disease.

A pill might provide desire to relapsed lymphoma and leukemia patients A pill that suppresses a key regulator of cancer growth may provide desire to relapsed leukemia and lymphoma sufferers running out of treatment options for his or her aggressive, treatment-resistant disease, today in Blood according to three reports published online, the journal of the American Society of Hematology. Sufferers with blood cancer are administered a combination of chemotherapy and immunotherapy typically, the latter using the body's have immune system to greatly help fight disease, while a first line of treatment. While chemotherapy provides traditionally prevailed in destroying tumor cells, it is accompanied by many dangerous side effects and patients develop resistance typically, prompting researchers to investigate new targeted therapies which may be able to block the creation of cancer cells while leaving normal cells unharmed .